These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 35917595

  • 1. Levels of eicosanoids in nasal secretions associated with nasal polyp severity in chronic rhinosinusitis.
    Nordström A, Jangard M, Svedberg M, Ryott M, Kumlin M.
    Prostaglandins Leukot Essent Fatty Acids; 2022 Sep; 184():102474. PubMed ID: 35917595
    [Abstract] [Full Text] [Related]

  • 2. Mucosal LTE4, PGD2 and 15(S)-HETE as potential prognostic markers for polyp recurrence in chronic rhinosinusitis.
    Nordström A, Jangard M, Ryott M, Tang X, Svedberg M, Kumlin M.
    Prostaglandins Other Lipid Mediat; 2024 Oct; 174():106886. PubMed ID: 39179198
    [Abstract] [Full Text] [Related]

  • 3. Prostaglandin, leukotriene, and lipoxin balance in chronic rhinosinusitis with and without nasal polyposis.
    Pérez-Novo CA, Watelet JB, Claeys C, Van Cauwenberge P, Bachert C.
    J Allergy Clin Immunol; 2005 Jun; 115(6):1189-96. PubMed ID: 15940133
    [Abstract] [Full Text] [Related]

  • 4. Nasal polyp antibody-secreting cells display proliferation signature in aspirin-exacerbated respiratory disease.
    Sohail A, Hacker J, Ryan T, McGill A, Bergmark R, Bhattacharyya N, Lee SE, Maxfield A, Roditi R, Julé AM, Griffith A, Lederer J, Laidlaw TM, Buchheit KM.
    J Allergy Clin Immunol; 2024 Feb; 153(2):527-532. PubMed ID: 37898408
    [Abstract] [Full Text] [Related]

  • 5. Cytokines in Chronic Rhinosinusitis. Role in Eosinophilia and Aspirin-exacerbated Respiratory Disease.
    Stevens WW, Ocampo CJ, Berdnikovs S, Sakashita M, Mahdavinia M, Suh L, Takabayashi T, Norton JE, Hulse KE, Conley DB, Chandra RK, Tan BK, Peters AT, Grammer LC, Kato A, Harris KE, Carter RG, Fujieda S, Kern RC, Schleimer RP.
    Am J Respir Crit Care Med; 2015 Sep 15; 192(6):682-94. PubMed ID: 26067893
    [Abstract] [Full Text] [Related]

  • 6. Systemic expression of inflammatory mediators in patients with chronic rhinosinusitis and nasal polyps with and without Aspirin Exacerbated Respiratory Disease.
    Pezato R, Świerczyńska-Krępa M, Niżankowska-Mogilnicka E, Holtappels G, De Ruyck N, Sanak M, Derycke L, Van Crombruggen K, Bachert C, Pérez-Novo CA.
    Cytokine; 2016 Jan 15; 77():157-67. PubMed ID: 26615369
    [Abstract] [Full Text] [Related]

  • 7. Inflammatory mediators in nasal secretions of patients with nasal polyposis with and without aspirin sensitivity.
    Perić A, Gaćeša D, Cvetković G, Vojvodić D.
    Immun Inflamm Dis; 2023 Feb 15; 11(2):e791. PubMed ID: 36840483
    [Abstract] [Full Text] [Related]

  • 8. Expression of eicosanoid receptors subtypes and eosinophilic inflammation: implication on chronic rhinosinusitis.
    Pérez-Novo CA, Claeys C, Van Cauwenberge P, Bachert C.
    Respir Res; 2006 May 12; 7(1):75. PubMed ID: 16689996
    [Abstract] [Full Text] [Related]

  • 9. Rapid and sustained effect of dupilumab on clinical and mechanistic outcomes in aspirin-exacerbated respiratory disease.
    Buchheit KM, Sohail A, Hacker J, Maurer R, Gakpo D, Bensko JC, Taliaferro F, Ordovas-Montanes J, Laidlaw TM.
    J Allergy Clin Immunol; 2022 Aug 12; 150(2):415-424. PubMed ID: 35460728
    [Abstract] [Full Text] [Related]

  • 10. Elevated Urine Leukotriene E4 Is Associated With Worse Objective Markers in Nasal Polyposis Patients.
    Choby G, O'Brien EK, Smith A, Barnes J, Hagan J, Stokken JK, Strumpf A, Mattos JL, Payne SC, Divekar R.
    Laryngoscope; 2021 May 12; 131(5):961-966. PubMed ID: 33001452
    [Abstract] [Full Text] [Related]

  • 11. Mepolizumab targets multiple immune cells in aspirin-exacerbated respiratory disease.
    Buchheit KM, Lewis E, Gakpo D, Hacker J, Sohail A, Taliaferro F, Berreondo Giron E, Asare C, Vukovic M, Bensko JC, Dwyer DF, Shalek AK, Ordovas-Montanes J, Laidlaw TM.
    J Allergy Clin Immunol; 2021 Aug 12; 148(2):574-584. PubMed ID: 34144111
    [Abstract] [Full Text] [Related]

  • 12. Induced sputum eicosanoids during aspirin bronchial challenge of asthmatic patients with aspirin hypersensitivity.
    Mastalerz L, Celejewska-Wójcik N, Wójcik K, Gielicz A, Januszek R, Cholewa A, Stręk P, Sanak M.
    Allergy; 2014 Nov 12; 69(11):1550-9. PubMed ID: 25123806
    [Abstract] [Full Text] [Related]

  • 13. Retinoic acid promotes fibrinolysis and may regulate polyp formation.
    Sakashita M, Takabayashi T, Imoto Y, Homma T, Yoshida K, Ogi K, Kimura Y, Kato A, Stevens WW, Smith SS, Welch KC, Norton JE, Suh LA, Carter RG, Hulse KE, Seshadri S, Min JY, Pothoven KL, Conley DB, Tan BK, Harris KE, Kern RC, Haruna S, Matsuwaki Y, Ochiai R, Fujieda S, Schleimer RP.
    J Allergy Clin Immunol; 2022 Nov 12; 150(5):1114-1124.e3. PubMed ID: 35728655
    [Abstract] [Full Text] [Related]

  • 14. Association of air pollutants, airborne occupational exposures, and chronic rhinosinusitis disease severity.
    Velasquez N, Moore JA, Boudreau RM, Mady LJ, Lee SE.
    Int Forum Allergy Rhinol; 2020 Feb 12; 10(2):175-182. PubMed ID: 31661614
    [Abstract] [Full Text] [Related]

  • 15. Trial of thromboxane receptor inhibition with ifetroban: TP receptors regulate eicosanoid homeostasis in aspirin-exacerbated respiratory disease.
    Laidlaw TM, Buchheit KM, Cahill KN, Hacker J, Cho L, Cui J, Feng C, Chen CC, Le M, Israel E, Boyce JA.
    J Allergy Clin Immunol; 2023 Sep 12; 152(3):700-710.e3. PubMed ID: 37068712
    [Abstract] [Full Text] [Related]

  • 16. Microparticles in nasal lavage fluids in chronic rhinosinusitis: Potential biomarkers for diagnosis of aspirin-exacerbated respiratory disease.
    Takahashi T, Kato A, Berdnikovs S, Stevens WW, Suh LA, Norton JE, Carter RG, Harris KE, Peters AT, Hulse KE, Grammer LC, Welch KC, Shintani-Smith S, Tan BK, Conley DB, Kern RC, Bochner BS, Schleimer RP.
    J Allergy Clin Immunol; 2017 Sep 12; 140(3):720-729. PubMed ID: 28238741
    [Abstract] [Full Text] [Related]

  • 17. The expression of cancerous inhibitor protein phosphatase 2A in chronic rhinosinusitis with nasal polyps.
    Terna E, Luukkainen A, Seppälä M, Renkonen R, Huhtala H, Tommola S, Paavonen T, Kauppi P, Tynninen O, Jeskanen L, Toppila-Salmi S.
    Acta Otolaryngol; 2016 Nov 12; 136(11):1173-1179. PubMed ID: 27348236
    [Abstract] [Full Text] [Related]

  • 18. IL-5Rα marks nasal polyp IgG4- and IgE-expressing cells in aspirin-exacerbated respiratory disease.
    Buchheit KM, Dwyer DF, Ordovas-Montanes J, Katz HR, Lewis E, Vukovic M, Lai J, Bankova LG, Bhattacharyya N, Shalek AK, Barrett NA, Boyce JA, Laidlaw TM.
    J Allergy Clin Immunol; 2020 Jun 12; 145(6):1574-1584. PubMed ID: 32199912
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.